Organon (OGN) Cash from Financing Activities (2020 - 2026)

Organon has reported Cash from Financing Activities for 7 years, with the latest figure at -$12.0 million in Q2 2026.

• Cash from Financing Activities for Q2 2026 came in at -$12.0 million, up 94.62% year-over-year; the trailing twelve-month figure through Jun 2026 was -$313.0 million (up 31.66% YoY), and the FY2025 annual result was -$561.0 million, down 52.45% from the prior year.
• Cash from Financing Activities rose to -$12.0 million in Q2 2026, from -$38.0 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at -$12.0 million in Q2 2026 and troughed at -$326.0 million in Q1 2023.
• A 5-year average of -$110.1 million and a median of -$80.0 million in 2022 frame the typical range for Cash from Financing Activities.
• The widest annual swing landed in 2022, when Cash from Financing Activities plunged 327.78%; it then surged 94.62% in 2026.
• A 5-year view of Cash from Financing Activities shows it stood at -$82.0 million in 2022, then increased by 6.1% to -$77.0 million in 2023, then fell by 6.49% to -$82.0 million in 2024, then plunged by 128.05% to -$187.0 million in 2025, then surged by 93.58% to -$12.0 million in 2026.
• Per Business Quant data, the three most recent Cash from Financing Activities figures were -$12.0 million in Q2 2026, -$38.0 million in Q1 2026, and -$187.0 million in Q4 2025.